You are here

Article metrics

Article menu
Download PDFPDF
Uterine Cancer
Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer

 

Online download statistics by month:

Online download statistics by month: January 2019 to October 2024

AbstractFullPdf
Jan 2019400
Feb 20191200
Mar 20193601
Apr 2019800
May 20191401
Jun 20191800
Jul 20192400
Aug 20193001
Sep 20192801
Oct 20191200
Nov 20192803
Dec 20192300
Jan 20203101
Feb 2020800
Mar 2020600
Apr 20202500
May 20203300
Jun 20201500
Jul 20202200
Aug 20202600
Sep 20201400
Oct 20202300
Nov 20202100
Dec 20202200
Jan 20213501
Feb 20213701
Mar 20214302
Apr 20214502
May 2021900
Jun 2021301
Jul 2021202
Aug 2021100
Sep 2021200
Oct 20212901
Nov 20215401
Dec 20214301
Jan 20223600
Feb 20222803
Mar 20223602
Apr 20223700
May 20225001
Jun 20225801
Jul 20224002
Aug 20224803
Sep 20227000
Oct 20223600
Nov 20224204
Dec 20224000
Jan 20231902
Feb 20236700
Mar 20231600
Apr 20231000
May 20232100
Jun 20233801
Jul 20231500
Aug 2023600
Sep 20231501
Oct 20235403
Nov 20232700
Dec 20234101
Jan 20241000
Feb 20243000
Mar 20242100
Apr 20243100
May 20242600
Jun 20247400
Jul 20241900
Aug 20245801
Sep 20244100
Oct 2024400
Total1950045